Indeed, it has been demonstrated that people with 22q11DS have reduced COMT gene expression [24, 25], enzyme activity [25] and alterations in dopaminergic neurotransmission [26, 27]. The gene discussed is COMT; the disease is 22q11.2 deletion syndrome.